24 HR glycine 25 MG / isoleucine 50 MG / ubidecarenone 100 MG Extended Release Oral Tablet

RxCUI
1494979
RxNorm name
24 HR glycine 25 MG / isoleucine 50 MG / ubidecarenone 100 MG Extended Release Oral Tablet
Display name
Glycine/Isoleucine/Ubidecarenone XR (Oral Pill)
Full name
24 HR glycine 25 MG / isoleucine 50 MG / ubidecarenone 100 MG Extended Release Oral Tablet
Term type
SCD
Status
Active
Strength
25-50-100 mg
Dose form
24 HR XR Tab
Route
Oral Pill
Updated
2026-11-16 14:57:36

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
052014
Active start
052014
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
ubidecarenone100 MG / 1 EACHubidecarenoneubidecarenone
glycine25 MG / 1 EACHglycineglycine
isoleucine50 MG / 1 EACHisoleucineisoleucine

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Extended Release Oral Tablet316945

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
ubidecarenone21406
glycine4919
isoleucine6033

Source Vocabulary Codes#

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 1 matching rows.

NDC11, Source, Active table
NDC11SourceActive
68016046500rxnav_ndcsyes

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCC01EBOther cardiac preparationsATC1-4ubidecarenone
ATCB05CXOther irrigating solutionsATC1-4glycine
MEDRTD005998GlycineCHEMhas_ingredientglycine
MEDRTD007532IsoleucineCHEMhas_ingredientisoleucine
MEDRTD014451UbiquinoneCHEMhas_ingredientubidecarenone
MEDRTD000787Angina PectorisDISEASEmay_treatubidecarenone
MEDRTD001002AnuriaDISEASEci_withglycine
MEDRTD004342Drug HypersensitivityDISEASEci_withglycine
MEDRTD004342Drug HypersensitivityDISEASEci_withubidecarenone
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_preventubidecarenone
MEDRTD015673Fatigue Syndrome, ChronicDISEASEmay_treatubidecarenone
MEDRTD006333Heart FailureDISEASEmay_treatubidecarenone
MEDRTD006816Huntington DiseaseDISEASEmay_treatubidecarenone
MEDRTD006949HyperlipidemiasDISEASEmay_treatubidecarenone
MEDRTD006973HypertensionDISEASEmay_treatubidecarenone
MEDRTD009750Nutritional and Metabolic DiseasesDISEASEmay_preventglycine
MEDRTD009750Nutritional and Metabolic DiseasesDISEASEmay_treatglycine
MEDRTD010437Peptic UlcerDISEASEmay_treatglycine
MEDRTN0000000142Biological Macromolecular ActivityMOAhas_moaglycine
MEDRTN0000000163Enzyme InteractionsMOAhas_moaubidecarenone
MEDRTN0000009063Glycine Activity AlterationPEhas_peglycine
MEDRTN0000009748Metabolic Activity AlterationPEhas_peglycine
MEDRTN0000009925Unknown Physiological EffectPEhas_peubidecarenone

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH25 MG / 50 MG / 100 MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESQUANTITY24 HR
ATTRIBUTESRXNAV_HUMAN_DRUGUS
NAMESPrescribable Synonymcoenzyme Q10 100 MG / glycine 25 MG / isoleucine 50 MG 24HR Extended Release Oral Tablet
SOURCESSourceGold Standard Alchemy